|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4866 USD | +12.10% |
|
-6.32% | +8.13% |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.9M 1.75M 1.63M 3.09M 207M 3.14M 20.98M 8.15M 102M 8.16M 7.99M 351M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.79M 10.83M 10.1M 19.15M 1.28B 19.44M 130M 50.55M 631M 50.61M 49.52M 2.17B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
69.2% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | +12.10% | ||
| 1 week | -6.32% | ||
| Current month | +12.09% | ||
| 1 month | +10.59% | ||
| 3 months | +62.19% | ||
| 6 months | +11.86% | ||
| Current year | +8.13% |
| 1 week | 0.43 |  | 0.49 |
| 1 month | 0.39 | | 0.52 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 15/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 30/03/2016 |
| Director of Finance/CFO | 46 | 20/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 26/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 16/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 15/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/09/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 27/08/25 | Free | Director | 50,000 | 0.6987% | ||
| 27/08/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +12.10% | -6.32% | +21.64% | -43.42% | 3.53M | |
| +3.45% | +7.65% | +55.77% | +158.84% | 1,082B | |
| -1.16% | +7.42% | +69.09% | +58.92% | 633B | |
| -0.77% | +7.37% | +36.87% | +93.77% | 461B | |
| -0.35% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.56% | +1.17% | +41.96% | +39.64% | 301B | |
| -0.08% | +1.49% | +32.40% | +44.75% | 292B | |
| -1.54% | +2.58% | -25.52% | -39.75% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +0.40% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +2.55% | +4.55% | +30.73% | +47.65% | 369.97B | |
| Weighted average by Cap. | +1.37% | +1.96% | +42.23% | +81.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.17M 18.54M 17.28M 32.77M 2.2B 33.27M 223M 86.5M 1.08B 86.6M 84.74M 3.72B | 24.22M 21.17M 19.45M 18.13M 34.39M 2.31B 34.92M 234M 90.79M 1.13B 90.89M 88.94M 3.91B |
| Net income | -5.27M -4.6M -4.23M -3.94M -7.48M -501M -7.59M -50.8M -19.75M -247M -19.77M -19.35M -849M | -3.2M -2.8M -2.57M -2.4M -4.55M -305M -4.62M -30.89M -12.01M -150M -12.02M -11.76M -517M |
| Net Debt | 10.2M 8.91M 8.19M 7.64M 14.48M 971M 14.7M 98.35M 38.23M 477M 38.28M 37.45M 1.64B | 11.31M 9.88M 9.08M 8.47M 16.06M 1.08B 16.3M 109M 42.39M 529M 42.44M 41.53M 1.82B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/07/26 | US$0.4866 | +12.10% | 100 |
| 30/06/26 | US$0.4341 | -16.43% | 1,000 |
| 25/06/26 | US$0.5194 | -0.02% | 1,500 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
